(Rac)-Ruxolitinib-d9(Synonyms: (Rac)-INCB18424-d9)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

(Rac)-Ruxolitinib-d9 (Synonyms: (Rac)-INCB18424-d9)

(Rac)-Ruxolitinib D9 ((Rac)-INCB18424 D9) 是氘代的 (Rac)-Ruxolitinib。(Rac)-Ruxolitinib 是 JAK2 抑制剂。

(Rac)-Ruxolitinib-d9(Synonyms: (Rac)-INCB18424-d9)

(Rac)-Ruxolitinib-d9 Chemical Structure

CAS No. : 2469553-67-9

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

(Rac)-Ruxolitinib D9 ((Rac)-INCB18424 D9) is the deuterium labeled (Rac)-Ruxolitinib. (Rac)-Ruxolitinib is a JAK2 inhibitor[1].

体内研究
(In Vivo)

(Rac)-Ruxolitinib氘代物

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

315.42

Formula

C17H9D9N6
CAS 号

2469553-67-9
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Yaoyu CHEN, et al. Combination therapy comprising an alk2 inhibitor and a jak2 inhibitor. Patent WO2021102258A1

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务